Niloofar Rahmani

Array ( [id] => 895796 [patent_doc_number] => 07342124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof' [patent_app_type] => utility [patent_app_number] => 10/817532 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17130 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/342/07342124.pdf [firstpage_image] =>[orig_patent_app_number] => 10817532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348893 [patent_doc_number] => 07495009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Imidazopyridine derivatives as melancortin receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/550122 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16133 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495009.pdf [firstpage_image] =>[orig_patent_app_number] => 10550122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205697 [patent_doc_number] => 20070027179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Azaindole derivatives, preparations thereof, uses thereof and compositions containing them' [patent_app_type] => utility [patent_app_number] => 10/550663 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18518 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027179.pdf [firstpage_image] =>[orig_patent_app_number] => 10550663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705732 [patent_doc_number] => 20060194780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Bicyclic piperidine derivatives as melanocortin-4 receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/548782 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28749 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194780.pdf [firstpage_image] =>[orig_patent_app_number] => 10548782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609130 [patent_doc_number] => 20060270646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Jnk inhibitors' [patent_app_type] => utility [patent_app_number] => 10/548163 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29338 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 64 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270646.pdf [firstpage_image] =>[orig_patent_app_number] => 10548163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404822 [patent_doc_number] => 07288655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'α v integrin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/547407 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7860 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288655.pdf [firstpage_image] =>[orig_patent_app_number] => 10547407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875420 [patent_doc_number] => 20060167040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Pyrazolopyridine derivates' [patent_app_type] => utility [patent_app_number] => 10/547232 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55537 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167040.pdf [firstpage_image] =>[orig_patent_app_number] => 10547232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433029 [patent_doc_number] => 20040162310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Tetrahydropyridoethers' [patent_app_type] => new [patent_app_number] => 10/783512 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6092 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162310.pdf [firstpage_image] =>[orig_patent_app_number] => 10783512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334334 [patent_doc_number] => 07507746 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Enantiomer of tenatoprazole and the use thereof in therapy' [patent_app_type] => utility [patent_app_number] => 10/546485 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3788 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507746.pdf [firstpage_image] =>[orig_patent_app_number] => 10546485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107959 [patent_doc_number] => 20070066837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Podophyllotoxin derivatives as antitumor agents' [patent_app_type] => utility [patent_app_number] => 10/545838 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6944 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066837.pdf [firstpage_image] =>[orig_patent_app_number] => 10545838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 285553 [patent_doc_number] => 07550480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 10/545565 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28619 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550480.pdf [firstpage_image] =>[orig_patent_app_number] => 10545565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255581 [patent_doc_number] => 20050075365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Novel triazolo-pyridines as anti-inflammatory compounds' [patent_app_type] => utility [patent_app_number] => 10/776953 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29002 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075365.pdf [firstpage_image] =>[orig_patent_app_number] => 10776953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632377 [patent_doc_number] => 20060148847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors' [patent_app_type] => utility [patent_app_number] => 10/543828 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8686 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148847.pdf [firstpage_image] =>[orig_patent_app_number] => 10543828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997772 [patent_doc_number] => 20050137401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Process for the preparation of tetrahydrothieno [3,2-C] pyridine derivatives' [patent_app_type] => utility [patent_app_number] => 10/774506 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2351 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137401.pdf [firstpage_image] =>[orig_patent_app_number] => 10774506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 453253 [patent_doc_number] => 07247643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => '8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors' [patent_app_type] => utility [patent_app_number] => 10/544027 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9186 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247643.pdf [firstpage_image] =>[orig_patent_app_number] => 10544027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7605184 [patent_doc_number] => 07115745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Benzyl urea and thiourea derivatives' [patent_app_type] => utility [patent_app_number] => 10/775405 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8699 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115745.pdf [firstpage_image] =>[orig_patent_app_number] => 10775405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 868706 [patent_doc_number] => 07365080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof' [patent_app_type] => utility [patent_app_number] => 10/543065 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19468 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365080.pdf [firstpage_image] =>[orig_patent_app_number] => 10543065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643426 [patent_doc_number] => 20060281881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Storage stable cyclic ketone peroxide compositions' [patent_app_type] => utility [patent_app_number] => 10/543606 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3623 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281881.pdf [firstpage_image] =>[orig_patent_app_number] => 10543606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 463827 [patent_doc_number] => 07238706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => '4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/764229 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23578 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238706.pdf [firstpage_image] =>[orig_patent_app_number] => 10764229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310676 [patent_doc_number] => 20040142962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => '4\',4\"-substituted 3alpha-(diphenylmethoxy) tropane analogs for treatment of mental disorders' [patent_app_type] => new [patent_app_number] => 10/752840 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4423 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142962.pdf [firstpage_image] =>[orig_patent_app_number] => 10752840 [rel_patent_id] =>[rel_patent_doc_number] =>)